ArticleHealthcare (Basel, Switzerland)2023

The Utilization of Glucagon-like Peptide 1 Agonists and Risk of Following External Eye Diseases in Type 2 Diabetes Mellitus Individuals: A Population-Based Study.

Ying-Chi Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.